Carthona Capital is a hands-on, proactive, and thematic venture capital investor based in Sydney, Australia that invests globally.
Business Model:
Revenue: $2.8M
Employees: 51-200
Address: 1 Alfred Street
City: Sydney
State: new south wales
Zip: 2000
Country: AU
Carthona Capital is a hands-on, proactive, and thematic venture capital investor based in Sydney, Australia that invests globally. Carthona Capital was founded in 2014 when a group of like-minded venture investors came together to invest on a deal-by-deal basis. Since then, Carthona Capital has shifted to a more traditional venture capital fund structure, and is now deploying its third fund with approximately $400m in funds under management from a mix of Institutional (Superannuation), Family Office and High Net-worth investors. Carthona Capital likes to invest very early - their initial investment into a business is usually at the Pre-Seed, Seed, or Series A stages. Carthona then likes to follow-on strongly and continue to deploy larger amounts of capital as a business matures.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
12/2017 | Daedalean | Venture Round | - |
5/2021 | Driva | Seed Round | 2.3M |
4/2022 | Reach Alternative Investments | Seed Round | 0 |
2/2014 | Credible | Seed Round | 0 |
1/2015 | Vendri | Seed Round | - |
8/2017 | Medius Health | Pre Seed Round | 939.2k |
3/2021 | DeferIt | Series B | 11.4M |
3/2015 | Rubicor | Post-IPO Equity | 596.2k |
8/2014 | Neoclinical | Seed Round | 465.2k |
11/2016 | The Service Manager (TSM) | Venture Round | 1.3M |
1/2016 | Ramp | Venture Round | 350k |
2/2019 | Medius Health | Seed Round | 2.1M |
7/2019 | Daedalean | Venture Round | 11.9M |
10/2018 | Cherre | Seed Round | 9M |
7/2015 | Affiniti | Venture Round | 572.7k |
7/2022 | InDebted | Venture Round | 0 |
10/2020 | Salad Technologies | Seed Round | 0 |
9/2019 | Roubler | Series A | 3.3M |
4/2021 | Cherre | Series B | 50M |
10/2015 | Credible | Series A | 11.6M |
5/2015 | Airtasker | Series A | 0 |
5/2016 | Sparesbox | Convertible Note | 730.9k |
12/2017 | Ouster | Series A | 27M |
5/2015 | Iotera | Seed Round | 1M |
12/2016 | Zero Latency | Series B | 7M |
11/2017 | Overclock Labs | Seed Round | 0 |
9/2014 | Ingogo | Series A | 6.9M |
9/2022 | CIM | Series A | 6.7M |
12/2019 | Replica Studios | Seed Round | 2.5M |
1/2019 | DeferIt | Series A | - |
3/2022 | Salad Technologies | Series A | 0 |
1/2016 | Sparesbox | Seed Round | 419.7k |
11/2015 | PARts | Seed Round | - |
11/2022 | Josef | Seed Round | 3.5M |
1/2018 | Sparesbox | Series B | - |
5/2014 | Sparesbox | Seed Round | 463k |
9/2021 | Skript | Seed Round | - |
8/2016 | Sparesbox | Series A | 2.7M |
9/2020 | Ouster | Series B | 42M |
5/2021 | Paytron | Seed Round | 2.3M |
1/2017 | Credible | Series B | 10M |
10/2019 | Valiant | Series B | 0 |
3/2017 | Peerspace | Series A | 0 |
7/2018 | Peerspace | Series B | 0 |
3/2012 | Search Party | Angel Round | 227.1k |
7/2021 | InDebted | Series B | 18.3M |
5/2022 | Layer | Seed Round | 2.7M |
11/2014 | Zero Latency | Venture Round | 862.4k |
9/2018 | Valiant | Series A | 4M |
3/2016 | Rubicor | Post-IPO Equity | - |
12/2015 | Zero Latency | Venture Round | 1.1M |
5/2021 | Qsic | Series A | 3.1M |
4/2019 | Agerris | Seed Round | 4.6M |
2/2020 | Cherre | Series A | 16M |
1/2017 | Ouster | Seed Round | 3M |
10/2021 | Pathzero | Series A | 0 |
12/2014 | Sparesbox | Seed Round | 822.1k |
9/2018 | Pulsa | Seed Round | - |
2/2015 | Credible | Seed Round | 0 |
1/2022 | Daedalean | Series B | 0 |
9/2014 | Synata | Seed Round | 0 |
5/2022 | Post-IPO Equity | 0 | |
11/2021 | Particular Audience | Series A | 7.2M |
7/2019 | Particular Audience | Pre Seed Round | 1.3M |
1/2016 | Trustify | Seed Round | 5M |
1/2021 | Paytron | Seed Round | 1M |
12/2022 | Pathzero | Series A | 5.8M |
10/2017 | Paratus Clinical | Venture Round | 1.1M |
9/2015 | Paratus Clinical | Seed Round | - |
3/2022 | Cascade Strategy | Series A | 0 |
2/2016 | Siftery | Seed Round | 4M |
3/2016 | Savara Pharmaceuticals | Series C | 20M |
5/2009 | Life360 | Pre Seed Round | 50k |
3/2015 | Neoclinical | Seed Round | 468.9k |
7/2016 | ResponSight | Seed Round | 876k |
3/2015 | HoneyBook | Series B | 0 |
2/2020 | InDebted | Series A | 14M |
4/2015 | ResponSight | Seed Round | 57k |
3/2022 | Driva | Seed Round | 0 |
12/2022 | SafeStack | Seed Round | 2.5M |
10/2021 | SafeStack | Seed Round | 1.6M |
7/2020 | Particular Audience | Seed Round | 567.9k |
7/2012 | Search Party | Angel Round | 867.5k |
3/2015 | Ramp | Venture Round | 457.4k |
5/2015 | PARts | Seed Round | - |
6/2020 | Pulsa | Seed Round | - |
7/2022 | InDebted | Venture Round | 0 |
5/2022 | Layer | Seed Round | 0 |
4/2022 | Reach Alternative Investments | Seed Round | 0 |
3/2022 | Salad Technologies | Series A | 0 |
3/2022 | Driva | Seed Round | 0 |
3/2022 | Cascade Strategy | Series A | 0 |
1/2022 | Daedalean | Series B | 0 |
11/2021 | Particular Audience | Series A | 0 |
10/2021 | SafeStack | Seed Round | 0 |
10/2021 | Pathzero | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|